NCT00001768View on ClinicalTrials.gov

Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

June 30, 2000

Conditions
Autoimmune DiseasesMental Disorders Diagnosed in ChildhoodSchizophrenia
Interventions
DRUG

Intravenous immunoglobulin

Trial Locations (1)

20892

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00001768 - Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) | Biotech Hunter | Biotech Hunter